Press Releases July 7, 2026 04:54 PM

Pitanium Limited Notified of Anticipated Delisting from The Nasdaq Stock Market

Pitanium Limited faces imminent Nasdaq delisting following SEC trading suspension

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
PTNM

Pitanium Limited (Nasdaq: PTNM) has been notified by Nasdaq of its impending delisting scheduled for July 16, 2026, following a prolonged trading suspension imposed by the SEC. The securities remain halted and trading may shift to the OTC market if the delisting proceeds without successful appeal.

Pitanium Limited Notified of Anticipated Delisting from The Nasdaq Stock Market
PTNM
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Nasdaq has formally announced the delisting of Pitanium Limited due to regulatory and listing compliance issues.
  • SEC previously suspended trading in Pitanium's securities, indicating significant regulatory concerns.
  • Post-delisting, shares may only be traded over-the-counter, reducing liquidity and investor access.

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced today that it has notified Pitanium Limited (Nasdaq: PTNM) that its securities will be delisted from the Nasdaq Stock Market LLC on July 16, 2026, unless the company appeals to a Listing Qualifications Hearings Panel. The securities will remain halted, and unavailable to trade, until any appeal is resolved. Following removal from Nasdaq the securities may be eligible for trading in the over-the-counter market. 

Following a temporary trading suspension in the Company’s securities by the U.S. Securities and Exchange Commission (https://www.sec.gov/files/litigation/suspensions/2025/34-104165-ts.pdf) Nasdaq halted trading in the Company’s ordinary shares on October 18, 2025. Nasdaq has now determined that it is appropriate to use its authority under IM-5101-4 to delist the Company’s securities from Nasdaq.

For news and additional information about the company, please review the companies’ public filings or contact the company directly.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.  


Risks

  • Delisting will likely lead to sharply decreased stock liquidity and diminished investor confidence affecting the company's capital raising ability.
  • Regulatory scrutiny from the SEC raises concerns about the company's governance or financial disclosures, impacting the broader financial services and regulatory sector.
  • Transition to OTC trading may result in increased volatility and lower transparency, influencing retail and institutional investors in technology and related sectors.

More from Press Releases

MediciNova to Participate in the Maxim Growth Summit Oct 6, 2026 Quantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis Oct 6, 2026 FTAI Aviation Ltd. Announces Timing of Third Quarter 2026 Earnings and Conference Call Oct 6, 2026 Portillo's and OREO Brand Go Beyond the Ordinary This Halloween by Launching a Trio of Tantalizing Treats Oct 6, 2026 Applied Digital Secures Up to 1 GW of Potential Power Capacity in Finland, Marking First International Development in the Nordics Oct 6, 2026